Related Experiment Video
Updated: Dec 5, 2025
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.4K
Measuring human leukocyte antigen alloantibodies: beyond a binary decision.
Chelsea H Maguire1, Carrie A Schinstock2, Anat R Tambur1
1Comprehensive Transplant Center, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Current Opinion in Organ Transplantation
|October 15, 2020
Summary
Human leukocyte antigen antibody titration offers a quantitative measure beyond single antigen bead assays. This method aids in desensitization efficacy, guides treatment, and stratifies highly sensitized patients for transplantation.
Area of Science:
- Immunology
- Transplantation Science
- Clinical Chemistry
Background:
- Accurate measurement of human leukocyte antigen (HLA) antibodies is crucial for transplant recipients.
- Single antigen bead assays provide Mean Fluorescence Intensity (MFI), which lacks quantitative precision.
- This limitation impacts clinical decisions for patients awaiting or undergoing transplantation.
Purpose of the Study:
- To evaluate the utility of HLA antibody titration studies.
- To address the limitations of single antigen bead assays in quantifying antibody strength.
- To explore the prognostic value of antibody titration in transplantation.
Main Methods:
- Performing titration studies involving specific dilutions of patient sera.
- Analyzing results to overcome target-saturation issues in single antigen bead assays.
- Utilizing titration data to assess desensitization efficacy and stratify patient risk.
Main Results:
- Titration studies circumvent single antigen bead assay limitations, especially for highly sensitized patients.
- Antibody titers provide prognostic value, guiding desensitization treatments like plasmapheresis/intravenous immunoglobulin (PP/IVIg).
- Titration enables stratification of patients with very high calculated panel reactive antibodies (cPRA >99%) based on antibody strength, identifying those likely to benefit from desensitization.
Conclusions:
- HLA antibody titration offers prognostic value by quantifying antibody strength.
- Performing a limited number of dilutions provides relevant information cost-effectively.
- Titration data can optimize treatment strategies and improve outcomes for transplant candidates.
